Latest Clinical Studies on CBD Hemp Oil.
is a web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions, as well as Clinical Studies CBD Hemp Oil.
Clinical Studies on CBD Hemp Oil in IBS & Seizure Disorders:
Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder – This is a multicenter, open-label trial to assess the long-term safety and efficacy of Cannabidiol Oral Solution as adjunctive therapy for pediatric and adult subjects with treatment-resistant seizure disorders, including Lennox-Gastaut Syndrome (LGS) or Dravet Syndrome (DS).
2. The National Center for Biotechnology Information (NCBI)
NCBI is a national resource for molecular biology information. View the latest case studies on CBD Hemp Oil in the PubMed Directory.
Clinical Studies on CBD Hemp Oil on Inflammation:
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse – In conclusion, CBD, given after the inflammatory insult, attenuates injury and motility in intestinal models of inflammation.
is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies.
The endocannabinoid system as a target for the treatment of neurodegenerative disease – Examining the evidence implicating the endocannabinoid system in the cause, symptomatology or treatment of neurodegenerative disease.
The endocannabinoid system and cancer: therapeutic implication – Cannabis-like compounds offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.
IACM is a scientific society advocating the improvement of the legal situation for the use of the hemp plant and the cannabinoids, for therapeutic applications through promotion of research and dissemination of information.
View the multiple Clinical Studies CBD Hemp Oil including Multiple Sclerosis & Cervical Cancer:
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis – CBD was found to promote neuronal survival by inhibiting JNK and p38 MAP kinases. These results provide an interesting discovery about the regulation of the PI3K/Akt/mTOR pathway by cannabidiol administration, that could be a new potential therapeutic target for MS management.
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells – Cannabidiol rather than Cannabis sativa crude extracts prevent cell growth and induce cell death in cervical cancer cell lines.
NOTICE: These are just a few of the many CBD resources available for research.
FDA / FOOD AND DRUG ADMINISTRATION DISCLOSURE:
The content of this website has not been evaluated by the FDA and is not intended to diagnose treat mitigate or cure any disease.